Harness Cutting-Edge Genome Editing & Delivery Technologies to Accelerate Safe, Precise & Regulatory-Compliant Therapies from Discovery to the Clinic
The 6th Genome Editing Therapeutics Summit
2025 had been industry-defining for the genome editing space. With baby KJ successfully receiving the world’s first personalized CRISPR therapy, alongside continued innovation across in vivo and base editing, and rapid ex vivo clinical progress, the field stood at a pivotal juncture, ready to unlock the transformative potential of both established assets, and cutting-edge breakthroughs.
In an effort to capture this excitement, spotlight innovation and propel clinical progress, the 6th Genome Editing Therapeutics Summit addressed challenges and advancements in the application and delivery of novel gene editing technologies, including base, prime, epigenome editing and more, this forum serves as your lens into the future of genome editing.
Showcasing both clinical advances and cutting-edge technologies from Metagenomi, Beam Therapeutics, Prime Medicine, Epicrispr Bio, and Scribe Therapeutics, this meeting provided you with the critical learnings needed to optimize safety and durability, while building a robust clinical strategy to fast-track best-in-class therapeutics to more patients in need.
Explore the Full Event Guide
- Get a full overview of the agenda, speakers, and sessions in one place
- Preview featured case studies that we’ll be shining a light on CRISPR therapy
- Discover exclusive content such as keynote highlights, attendee benefits and more
- Share easily with colleagues and decision-makers to mobilize interest
Attending Companies Include
Explore the 2025 Agenda
Hear the latest industry breakthroughs and gain exclusive insights during our packed agenda, interactive roundtables, and panel discussions.
Partner With Us
Position yourself alongside other leading solution providers to ensure your brand is at the heart of biopharma deals.
Join Biopharma Experts
Be part of the hottest conversations with like-minded attendees spanning all stages of drug development and make critical connections during our dedicated networking sessions.